Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of California, San Diego |
---|---|
Information provided by: | University of California, San Diego |
ClinicalTrials.gov Identifier: | NCT00363753 |
Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.
Condition | Intervention | Phase |
---|---|---|
Transient Ischemic Attack Stroke Aspirin Clopidogrel |
Drug: aspirin versus clopidogrel |
Phase I |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack |
Estimated Enrollment: | 20 |
Study Start Date: | August 2006 |
Estimated Study Completion Date: | March 2007 |
Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, California | |
UCSD Hillcrest | |
San Diego, California, United States, 92103 | |
UCSD | |
San Diego, California, United States, 92103 |
Principal Investigator: | Matt B Jensen, MD | UCSD Stroke Center |
Study ID Numbers: | UCSD IRB #060452 |
Study First Received: | August 10, 2006 |
Last Updated: | March 30, 2007 |
ClinicalTrials.gov Identifier: | NCT00363753 History of Changes |
Health Authority: | United States: Institutional Review Board |
Transient ischemic attack Stroke Aspirin Clopidogrel |
Anti-Inflammatory Agents Ischemic Attack, Transient Cerebral Infarction Cyclooxygenase Inhibitors Stroke Vascular Diseases Central Nervous System Diseases Fibrinolytic Agents Cardiovascular Agents Ischemia Brain Diseases Cerebrovascular Disorders |
Fibrin Modulating Agents Aspirin Analgesics, Non-Narcotic Clopidogrel Brain Ischemia Platelet Aggregation Inhibitors Anti-Inflammatory Agents, Non-Steroidal Peripheral Nervous System Agents Analgesics Brain Infarction Antirheumatic Agents Infarction |
Anti-Inflammatory Agents Molecular Mechanisms of Pharmacological Action Cerebral Infarction Hematologic Agents Physiological Effects of Drugs Fibrinolytic Agents Brain Diseases Cerebrovascular Disorders Fibrin Modulating Agents Pathologic Processes Aspirin Sensory System Agents Therapeutic Uses Brain Ischemia Cardiovascular Diseases |
Anti-Inflammatory Agents, Non-Steroidal Analgesics Ischemic Attack, Transient Cyclooxygenase Inhibitors Nervous System Diseases Stroke Vascular Diseases Central Nervous System Diseases Enzyme Inhibitors Cardiovascular Agents Ischemia Pharmacologic Actions Analgesics, Non-Narcotic Clopidogrel Platelet Aggregation Inhibitors |